We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.
User:Elizabeth Yowell/ SandboxFinal
From Proteopedia
(Difference between revisions)
(New page: ==Your Heading Here (maybe something like 'Structure')== <StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene=''> This is a default text for you...) |
|||
| Line 1: | Line 1: | ||
| - | = | + | =SARS CoV-2 Protein Inhibitors (AHB2 and LCB1/LCB3)= |
| - | + | ||
| - | + | ||
| - | + | ||
| - | == | + | <StructureSection load='7UHB' size='350' frame= 'true' side= 'right' caption='AHB2 Inhibitor 7UHB' scene ='10/1075216/Practice/1'> |
| - | == | + | ==Introduction== |
| + | SARS-CoV-2 better known as Covid-19 sent the world into a [https://www.who.int/europe/emergencies/situations/covid-19 global pandemic]. In order to create a vaccine, it was essential to understand how SARS-CoV-2 infected us. | ||
| - | + | The enzyme angiotensin converting enzyme 2 (ACE2) is attached to our cell membranes and then can be bound to a receptor binding domain (RBD) <ref name="Borkotoky">DOI:10.1007/s11033-022-08193-4</ref>. The spike protein of SARS-CoV-2 enters our bodies and binds to the RBD, allowing the spike protein access to ACE2 and our host cells <ref name=”Jackson”>DOI:10.1038/s41580-021-00418-x</ref>. Once the spike protein has access to our host cells, it is able to further infect our cells and spread the virus throughout our bodies, causing us to get sick. In order to create an effective vaccine, the pathway between the spike protein and the RBD needed to be [https://www.sciencedirect.com/science/article/pii/S0166354223000190 interrupted]. | |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
Revision as of 20:10, 2 April 2025
SARS CoV-2 Protein Inhibitors (AHB2 and LCB1/LCB3)
| |||||||||||
